Contract notice: maintenance of the biomedical park
and integral equipment of electro-medicine equipment of the hc
This facility covers a 120,000 square-metre area and is situated in the Tuas Biomedical Park
. It will also include a biologics manufacturing facility that is likely to be completely operational by the end of 2018.
Any commercially promising technologies developed at Biopolis can potentially be manufactured locally, at Tuas Biomedical Park
. Located on the western tip of Singapore, the 280-hectare (692-acre) campus provides companies with access to skilled talent, research expertise, manufacturing capabilities, and transportation logistics.
Amgen plans to build a new manufacturing facility n the Tuas Biomedical Park
area of Singapore, investing approximately $200 million.The facility will initially focus on expanding manufacturing capabilities for monoclonal antibodies, and will be capable of manufacturing both clinical and commercial products.
The Tuas Biomedical Park
(TBP) plays an instrumental role in attracting global biopharmaceutical manufacturing activities to Singapore.